Wilson Therapeutics

Last updated: July 31, 2024

Jonas Hansson, CEO
Jonas Hansson, CEO
Sweden | Funding: $68.9M (+)

Website: https://www.wilsontherapeutics.com

Wilson Therapeutics is a biopharmaceutical company that committed to improving lives of patients with Wilson Disease through the development of new treatment options.